NBC 10 Philadelphia

Pfizer, Moderna, Johnson & Johnson: Comparing the 3 COVID Vaccines Now Available

With three coronavirus vaccines already approved for emergency use authorization in the U.S., how do the different available shots compare? Pfizer and Moderna's COVID vaccines have been available in ...

Pfizer: Is This Pharma Giant Finally A Bargain

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

How Recent Moves Are Rewriting the Story for Pfizer

Pfizer's fair value estimate has inched upward recently, rising from $28.86 to $29.08 per share. The discount rate has ...
MarketWatch

US Cancer Immunotherapy Forecast and Company Analysis Report 2025-2033 Featuring Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Pfizer, Novartis, Johnson & Johnson, Eli Lily ...

The "United States Cancer Immunotherapy Market Report by Products, Application, End User, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United ...

Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating

Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS ...